<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02412189</url>
  </required_header>
  <id_info>
    <org_study_id>TDamen</org_study_id>
    <nct_id>NCT02412189</nct_id>
  </id_info>
  <brief_title>Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia</brief_title>
  <official_title>Pressure-dependent Changes in Hematocrit and Plasma Volume During Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The arterial blood pressure affects the ratio between filtration and reabsorption of fluids
      in the circulating blood volume and thereby the hematocrit. During induction of anesthesia
      blood pressure, hemoglobin level and hematocrit decreases. The aim of the study is to
      evaluate weather a maintained blood pressure with norepinephrine during anesthesia induction
      reduces the decrease in hematocrit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      24 patients scheduled for coronary artery bypass surgery will be included and randomized to
      receive either norepinephrine in the dose needed to maintain pre-anesthesia blood pressure or
      to a control group and receive norepinephrine only if mean arterial pressure decreases below
      60 mmHg. Arterial blood gas will be analysed every ten minutes. Equal anesthesia in both
      groups will be monitored. No fluids will be infused. Noninvasive continuous hemoglobin
      measurement (SpHb) will be measured.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The magnitude and dynamics of the decrease in hematocrit during anesthesia induction</measure>
    <time_frame>70 minutes from anesthesia induction</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduced hematocrit decrease by vasopressor infusion maintained blood pressure</measure>
    <time_frame>70 minutes from anesthesia induction</time_frame>
    <description>To assess if the decrease in hematocrit can be reduced, by maintaining the blood pressure with vasopressor infusion</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Accuracy of continuous non-invasive hemoglobin monitoring (SpHb) to invasive Hb levels</measure>
    <time_frame>70 minutes from anesthesia induction</time_frame>
    <description>To evaluate if changes in invasive measured Hb levels, can be measured by continuous non-invasive hemoglobin monitoring (SpHb).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Hematocrit Change</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Ordinary anesthesia, mean arterial pressure allowed to decrease to 60 mmHg. If it is lower the patients will receive a norepinephrine infusion in order to raise the mean arterial pressure to 60 mmHg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maintained blood pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ordinary anaesthesia and maintained preanesthetic blood pressure by norepinephrine infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maintained blood pressure</intervention_name>
    <description>Norepinephrine therapy to maintain preanesthesia blood pressure</description>
    <arm_group_label>Maintained blood pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Norepinephrine therapy to maintain preanesthesia blood pressure</description>
    <arm_group_label>Maintained blood pressure</arm_group_label>
    <other_name>Vasopressor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective coronary artery surgery patients

        Exclusion Criteria:

          -  Age under 18 years

          -  untreated hypertension

          -  a reduced left ventricular systolic ejection fraction of 45 % or less

          -  diabetes mellitus

          -  former stroke and/or a known carotid artery stenosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Nygren, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sweden: Sahlgrenska University hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tor Damén, MD</last_name>
    <phone>+46313427873</phone>
    <email>tor.damen@vgregion.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas Nygren, MD</last_name>
    <phone>+46313427444</phone>
    <email>andreas.nygren@aniv.gu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Nygren, MD PHD</last_name>
      <phone>+46313427444</phone>
      <email>andreas.nygren@aniv.gu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2015</study_first_submitted>
  <study_first_submitted_qc>April 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2015</study_first_posted>
  <last_update_submitted>April 4, 2015</last_update_submitted>
  <last_update_submitted_qc>April 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Tor Damén</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Plasma volume</keyword>
  <keyword>Vasopressor agents</keyword>
  <keyword>Continuous noninvasive hemoglobin measurement</keyword>
  <keyword>Coronary artery bypass</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 31, 2016</submitted>
    <returned>July 8, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

